Cancerous Lesions Manufacturers, Suppliers & Companies (Clinical Medicine)
-
Manufacturerbased in Brussels, BELGIUM
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments. The company is advancing its lead product ...
-
Manufacturerbased in Amsterdam, NETHERLANDS
Self-screen has a long history and track record in translational HPV related science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of HPV related cancer screening into routine practice. Our ...
The QIAsure - Methylation Test
The QIAsure Methylation Test is intended to be used as a triage test for women with a positive HPV DNA test or for women with ASC-US cytology to identify those women who need to be referred for colposcopy. The QIAsure Methylation Test is a multiplex ...
CONTACT SUPPLIER -
Manufacturerbased in Natick, MASSACHUSETTS (USA)
DYSIS Medical is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DYSIS Medical has developed a proprietary technology ...
-
Manufacturerbased in Watchung, NEW JERSEY (USA)
Based in Watchung, New Jersey, USA, GY Highland Biotech LLC is the sister company of Shaanxi Gaoyuan In Vitro Diagnostic Reagents Co., Ltd., an innovative solution researcher and manufacturer of in vitro diagnostics with a growing portfolio in ...
FRD™, Folate Receptor-mediated Detection Staining Solution
Structure and Composition: The Folate Receptor-mediated Detection (FRD™) staining solution is mainly composed of folic acid, reduced methylene blue, acetic acid, ascorbic acid, and dimethyl sulfoxide. Intended Use: The Folate ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you